Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Preserflo MicroShunt Versus Trabeculectomy [NA]

View source ↗

Summary

A clinical trial comparing the PreserFlo MicroShunt to trabeculectomy for open-angle glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PreserFlo MicroShunt
  • Trabeculectomy

Snippet

Sponsor: Medical University of Bialystok | Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder) | NA | Status: RECRUITING